MIG Verwaltungs AG is shaping the future by investing in young founders and enterprises with potentials. We support them with venture capital. Inform yourself here.
Employees: 1-10
Investment Type: Venture Capital
Portfolio 43
| Date | Name | Website | Total Raised | Location |
| 20.11.2025 | Ncodin | ncodin.com | $22.51M | France |
| 09.09.2025 | AMSilk Gmb... | amsilk.com | $162.18M | Germany |
| 24.07.2025 | ASTRA Ther... | astratherapeutics.com | $9.87M | Switzerlan... |
| 22.06.2023 | Look Up Sp... | lookupspace.com | $15.39M | France, Oc... |
| 30.03.2022 | Innatera | innatera.com | $43.35M | Netherland... |
| 30.03.2022 | Inbolt | inbolt.fr | - | - |
| 30.03.2022 | Creative B... | creativeballoons.de | $18.25M | Germany, B... |
| 30.03.2022 | NeraCare G... | melagenix.info | - | - |
| 30.03.2022 | Mimi | mimi.io | $25M | Germany, B... |
| 30.03.2022 | germanbion... | germanbionic.com | $20M | Germany, B... |
Show more
Persons 15
| Date | First Name | Last Name | Title | Location | |||
| - | Soren | Hein | Partner | linkedin.c... | - | s*h@mig.ag | - |
| - | Michael | Motschmann | Vorstand | linkedin.c... | - | m*m@mig.ag | - |
| - | Holger Cle... | Hinz, CEFA | Vice Chair... | linkedin.c... | - | i**o@mig.a... | - |
| - | Jürgen | Kosch | Vorstand /... | linkedin.c... | - | j*k@mig.ag | - |
| - | Giulietta | Walderdorf... | Working St... | linkedin.c... | - | g*w@mig.ag | - |
| - | Lovis | Fuhrmann | Investment... | linkedin.c... | - | l*f@mig.ag | - |
| - | Frederick | Michna | Principal | linkedin.c... | - | f*M@mig.ag | - |
| - | Oliver | Kahl | Principal | linkedin.c... | - | o*k@mig.ag | - |
| - | Andreas | Kastenbaue... | - | linkedin.c... | - | a*k@mig.ag | - |
| - | Matthias | Guth | Venture Pa... | linkedin.c... | - | m*g@mig.ag | - |
Show more
Mentions in press and media 24
| Date | Title | Description |
| 24.11.2025 | NcodiN Raises €16M for Tiny Lasers to Supercharge AI Chips | NcodiN, a French deeptech startup, secured €16M in seed funding. They're developing tiny lasers for AI chips. These lasers aim to boost speed and energy efficiency. The tech could revolutionize AI hardware. **NcodiN Secures €16M to Develop ... |
| 20.11.2025 | €16 million investment boosts NcodiN’s development of “world’s smallest laser” for AI chips | Paris-based NcodiN, a DeepTech startup innovating AI hardware infrastructure, has raised €16 million in Seed funding to enable scalable, energy-efficient computing through its proof-of-concept nanolasers. The round was led by German VC firm... |
| 20.11.2025 | NcodiN secures €16M seed investment led by MIG Capital | NcodiN, a French deeptech startup, has secured a €16 million seed investment led by MIG Capital AG through its MIG Fonds 17 and 18. The round also includes participation from Maverick Silicon, PhotonVentures, and Verve Ventures, along with ... |
| 15.09.2025 | AMSilk Secures €52M to Unleash Industrial Scale Bio-Silk Revolution | AMSilk, a leading innovator in biotech-derived materials, has secured a substantial €52 million in new funding. This significant capital infusion propels the company's ambitious strategy to drastically scale its industrial production of adv... |
| 09.09.2025 | AMSilk Raises €52M in Funding | AMSilk, a Neuried, Germany-based company developing advanced biomaterials made from silk-based proteins, raised €52M in funding. The round was led by ATHOS (AT Newtec), with participation from existing investors MIG Capital and Novo Holding... |
| 25.07.2025 | ASTRA Therapeutics Secures €8.3 Million Seed Funding, Revolutionizing Animal Health Parasiticides | ASTRA Therapeutics, a Swiss biotech innovator, recently secured €8.3 million in seed funding. This significant capital influx fuels its vital mission: pioneering precision parasiticides for animal health. ASTRA's unique ParaX platform engin... |
| 25.07.2025 | Frisches Kapital für die Parasitenbekämpfung | Das 2022 gegründete Biotech-Startup ASTRA Therapeutics entwickelt neuartige Parasitenwirkstoffe, sogenannte Parasitizide. Zur Anwendung kommen sollen die Wirkstoffe dereinst beispielsweise in der Veterinärmedizin, wo Parasiten durch Hemmun... |
| 24.07.2025 | ASTRA Therapeutics raises CHF 7.75M to advance precision parasiticides in animal health | Founded in 2022 by Dr. Natacha Gaillard and Dr. Ashwani Sharma, ASTRA Therapeutics focuses on eukaryotic pathogens—organisms that cause illness and death in animals, humans, and crops. Existing treatments in this area are increasingly limit... |
| 24.07.2025 | ASTRA Therapeutics raises CHF 7.75 million in seed financing round to advance precision Parasiticides for Animal Health | ASTRA Therapeutics raises CHF 7.75 million in seed financing round to advance precision Parasiticides for Animal Health Thu, Jul 24, 2025 10:52 CET Report this content Round co-led by MIG Capital (CHF 3 million) and Digitalis Ventures (CHF ... |
| 24.07.2025 | Swiss BioTech platform ASTRA Therapeutics raises €8.3 million to advance precision Parasiticides for animal health | Villigen-based ASTRA Therapeutics, a BioTech startup designing drugs against eukaryotic pathogens based on its proprietary platform, announced today they have raised a Seed funding round of €8.3 million. The round was led by VC firm MIG Cap... |
Show more